Kenneth Shaw

This inventor holds 52 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in GABA Receptor Ligands (CPC class A61K). Top assignees: Neurogen Corporation, Marinus Pharmaceuticals, Yale University. Active years: 1992-2021.

USPTO Granted Patents = 52 (Patent Applications = 2)

% Patents Active = 76.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.5

ph-index = 15

Forward Citations = 652(Granted Patents)

Forward Citations (Not Self Cited) = 601(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Clinton, CT (US) (2000 - 2001)
Weston, CT (US) (1992 - 2021)

Company Filing History:

Marinus Pharmaceuticals

Years Active: 1992-2021

Loading Chart...

Areas of Expertise:

Ganaxolone Formulations

Corticosteroid Nanoparticles

GABA Receptor Ligands

Bicyclic Compounds

Imidazo-Pyrimidines

Tricyclic Compounds

Fused Pyrrolecarboxamides

Bradykinin B2 Modulators

Pseudobase Benzo[c]Phenanthridines

Oxomidazopyridine-Carboxamides

Liquid Formulations

Solid Compositions

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11071740 - Method of treatment using nanoparticulate ganaxolone formulations (2021-07-27),

2. 9452176 - Solid ganaxolone compositions and methods for the making and use thereof (2016-09-27),

3. 9056116 - Liquid ganaxolone formulations and methods for the making and use thereof (2015-06-16),

4. 9029355 - Solid ganaxolone compositions and methods for the making and use thereof (2015-05-12),

5. 9017728 - Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof (2015-04-28),

6. 8618087 - Solid ganaxolone formulations and methods for the making and use thereof (2013-12-31),

7. 8455002 - Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof (2013-06-04),

8. 8367651 - Solid ganaxolone formulations and methods for the making and use thereof (2013-02-05),

9. 8362286 - Method for making 3α-hydroxy, 3β- substituted-5α-pregnan-20-ones (2013-01-29),

10. 8362028 - Pseudobase benzo[c]phenanthridines with improved efficacy, stability and safety (2013-01-29),

11. 8318714 - Liquid ganaxolone formulations and methods for the making and use thereof (2012-11-27),

12. 8022054 - Liquid ganaxolone formulations and methods for the making and use thereof (2011-09-20),

13. 7858609 - Solid ganaxolone formulations and methods for the making and use thereof (2010-12-28),

14. 7531550 - Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety (2009-05-12),

15. 7348326 - [object Object] (2008-03-25),

Title: Kenneth Shaw: A Pioneer in Innovation and Technology

Introduction: Kenneth Shaw, a visionary inventor hailing from Weston, CT (US), has made significant contributions to the world of inventions through his passion for innovation and commitment to creating a better future through technology. With 52 patents to his name, Shaw continues to inspire the next generation of inventors and shape the landscape of innovation for years to come.

Latest Patents: Shaw's latest patents include groundbreaking inventions such as "Method of treatment using nanoparticulate ganaxolone formulations" and "Solid ganaxolone compositions and methods for the making and use thereof." These patents highlight his ingenuity and dedication to pushing the boundaries of science and technology.

Career Highlights: Shaw has worked with leading companies in the pharmaceutical and biotechnology sectors, including Neurogen Corporation and Marinus Pharmaceuticals. His expertise and innovative spirit have played a pivotal role in advancing research and development in these industries, ultimately leading to transformative breakthroughs in healthcare.

Collaborations: Throughout his career, Shaw has collaborated with esteemed colleagues such as Alan J Hutchison and Mingbao Zhang. These partnerships have been instrumental in fostering a culture of innovation and driving forward-thinking projects that have had a lasting impact on the field of inventions.

Conclusion: Kenneth Shaw's remarkable journey as an inventor exemplifies the power of innovation and the potential to create positive change through technology. His trailblazing work serves as a beacon of inspiration for budding inventors and underscores the importance of pushing the boundaries of what is possible in the world of inventions.